Multiomics – News and Features
News
GeneGo Collaborates with the Netherlands Toxicogenomics
The 5 year, 25 Million Euro, multi-party collaboration will use toxicogenomics to develop highly predictive ‘omics-based screens.
News
Genstruct Announces New Collaboration with Pfizer in Drug Safety
Genstruct has entered into a Master Research Agreement with Pfizer designed to cover current and future collaborations.
News
Bug Guts Map Brings Scientists Closer to Understanding Different Bugs' Role in the Body
Scientists mapped the different species of bugs living in seven members of the same Chinese family.
News
BioSeek Initiates Collaboration with Dainippon Sumitomo Pharma
BioSeek will apply its BioMAP® Systems to support development of DSP's discovery programs in the fields of inflammation and metabolic diseases.
News
UC Berkeley Expands Molecular Toxicology Curriculum to Include GeneGo's Platform
UC Berkeley will expand the use of GeneGo’s MetaCore/MetaDrug Discovery Platform in their Computational Toxicology course and in undergrad honors research programs.
News
Uncovering a Map of Human Cancer Signaling
Scientists from NRC-BRI recently released a map of human cancer signaling that provides a framework for discovering preferred combinations of signaling cascades used by cancer cells.
News
Invitrogen Exclusively Licenses Click Chemistry-based Cell Proliferation Assays from Harvard University
Click-iT™ labeling and detection technology complements company's "click" chemistry portfolio.
News
BioSeek Initiates Systems Biology Compound Evaluation Collaboration with UCB
BioSeek will apply its BioMAP® systems to evaluate a number of UCB compounds across several target classes.
News
Elan Pharmaceuticals Joins Genego’s Metatox Consortium
The Consortium will be focused on developing systems biology tools for safety assessment of small molecule compounds and biological therapeutics.
News
ATCC Collaboration Aimed at Pancreatic Cancer Biomarker Development
ATCC collaborates with The Valley Hospital of Ridgewood, New Jersey to accelerate the development and validation of biomarkers for the early detection and treatment of pancreatic cancer.
Advertisement